Furthermore, we also found that low BUD31 expression was related to worse return-free survival (RFS) in patients diagnosed with kidney renal papillary cell and thyroid carcinoma (as demonstrated in Figure 2E,F). The gene discussed is BUD31; the disease is thyroid gland carcinoma.